67 related articles for article (PubMed ID: 16828727)
1. C-reactive protein in HIV-infected patients--could it be a marker of immunosuppression?
Muthu S; Cecelia AJ; Pulimi S; Ameedha L; Srinivas CN; Solomon SS; Narayan A; Balakrishnan P; Murugavel KG; Solomon S; Kumarasamy N
Clin Chim Acta; 2007 Feb; 376(1-2):246-7. PubMed ID: 16828727
[No Abstract] [Full Text] [Related]
2. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
[TBL] [Abstract][Full Text] [Related]
3. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
4. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
5. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
[TBL] [Abstract][Full Text] [Related]
7. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
8. Bound leptin is regulated by tumour necrosis factor-alpha in HIV-infected patients: a potential mediator of wasting?
Ockenga J; Widjaja A; Holtmannspötter M; Schmidt RE; Brabant G
AIDS; 1998 Nov; 12(16):2233-5. PubMed ID: 9833870
[No Abstract] [Full Text] [Related]
9. Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients.
Mauss S; Berger F; Kuschak D; Henke J; Hegener P; Wolf E; Schauseil S; Schmutz G
Antivir Ther; 2008; 13(8):1091-5. PubMed ID: 19195336
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection.
Samaras K; Gan SK; Peake PW; Carr A; Campbell LV
Obesity (Silver Spring); 2009 Jan; 17(1):53-9. PubMed ID: 19008869
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
12. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration.
Jaroszewicz J; Wiercinska-Drapalo A; Lapinski TW; Prokopowicz D; Rogalska M; Parfieniuk A
Antivir Ther; 2006; 11(5):641-5. PubMed ID: 16964834
[TBL] [Abstract][Full Text] [Related]
13. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of C-reactive protein in the therapeutic follow-up of infected patients].
Roger PM; Hung S; de Salvador F; Allieri-Rosenthal A; Farhad R; Pulcini C; Cua E
Med Mal Infect; 2009 May; 39(5):319-24. PubMed ID: 19403254
[TBL] [Abstract][Full Text] [Related]
15. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis.
Memiş D; Gursoy O; Tasdogan M; Süt N; Kurt I; Türe M; Karamanlioğlu B
J Clin Anesth; 2007 May; 19(3):186-91. PubMed ID: 17531726
[TBL] [Abstract][Full Text] [Related]
16. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
[TBL] [Abstract][Full Text] [Related]
17. Change in cardiovascular risk status after dental clearance.
Ellis JS; Averley PA; Preshaw PM; Steele JG; Seymour RA; Thomason JM
Br Dent J; 2007 May; 202(9):543-4. PubMed ID: 17496863
[TBL] [Abstract][Full Text] [Related]
18. Inflammation in the development of lung cancer: epidemiological evidence.
Engels EA
Expert Rev Anticancer Ther; 2008 Apr; 8(4):605-15. PubMed ID: 18402527
[TBL] [Abstract][Full Text] [Related]
19. Smartphone apps set to provide next generation of blood-testing technology.
Potticary J
Bioanalysis; 2012 Oct; 4(19):2326. PubMed ID: 23251915
[No Abstract] [Full Text] [Related]
20. Fibrinogen concentration in asymptomatic HIV-infected individuals.
Lefrère JJ; Ferrer-Le-Coeur F; Lambin P
AIDS; 1990 Oct; 4(10):1033. PubMed ID: 2261118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
